Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, Norris Medicines has informed that the trading window of the Company will remain closed from 1st October, 2023 till 48 hours of the declaration of the Unaudited financial statements for the quarter ended 30th September, 2023.
The above information is a part of company’s filings submitted to BSE.